Revolutionizing
Early Detection
We're on a mission to detect Parkinson's disease years earlier through AI-powered voice analysis, giving millions of people the chance for better outcomes.
Our Mission
To democratize early Parkinson's detection through accessible, AI-powered voice analysis technology that empowers individuals and healthcare providers worldwide.
We believe everyone deserves the chance for early intervention. By making advanced diagnostic tools accessible through a simple voice test, we're breaking down barriers to early detection.
Our Vision
A world where Parkinson's disease is detected years before symptoms appear, enabling proactive treatment and dramatically improving quality of life for millions.
We envision a future where AI-powered diagnostics are the standard of care, where early detection is accessible to everyone, and where Parkinson's progression can be significantly slowed or even prevented.
How It Started
Born from personal experience and powered by cutting-edge AI research
The Spark
Our founder's father was diagnosed with Parkinson's. By then, 60% of dopamine neurons were already lost. We knew there had to be a better way.
The Research
We assembled a team of AI researchers, neurologists, and engineers. Months of research revealed voice biomarkers could detect Parkinson's years earlier.
The Breakthrough
Our AI model achieved 92% accuracy in early detection. We knew we had something that could change millions of lives.
Our Core Values
The principles that guide everything we do
Patient First
Every decision we make starts with one question: How does this help patients? Their wellbeing is our north star.
Privacy & Security
Healthcare data is sacred. We employ bank-level encryption and never compromise on data protection.
Scientific Rigor
Every claim is backed by peer-reviewed research. We publish our findings and welcome scrutiny.
Accessibility
Advanced healthcare shouldn't be a luxury. We're committed to making our technology available to everyone.
Collaboration
We partner with leading medical institutions, researchers, and clinicians to advance the field together.
Continuous Innovation
AI evolves rapidly. We're constantly improving our models with new data and cutting-edge techniques.
Leadership Team
World-class experts united by a common mission
Dr. Sarah Chen
CEO & Co-Founder
Former Stanford AI researcher. PhD in Machine Learning. Lost her father to Parkinson's.
Dr. Michael Rodriguez
Chief Medical Officer
Neurologist with 20+ years experience. Professor at Johns Hopkins. Parkinson's specialist.
James Park
CTO & Co-Founder
Ex-Google engineer. Built ML systems serving billions. MIT Computer Science.
Dr. Emily Watson
Chief Science Officer
Published 50+ papers on voice biomarkers. Former NIH researcher. Oxford PhD.
Impact By The Numbers
Real results, real impact
Tests Completed
Accuracy Rate
Countries
Clinical Trial Participants
Training Samples
Voice Biomarkers
Years Earlier Detection
Uptime SLA
Awards & Recognition
Recognized by leading organizations worldwide
Best Healthcare AI Innovation
TechCrunch Disrupt 2024
Top 10 AI Startups
Forbes 2024
Digital Health Innovation Award
HIMSS 2024
Excellence in Medical AI
MIT Technology Review 2024
Breakthrough Technology
Fast Company 2024
Best Diagnostic Tool
MedTech Breakthrough 2024
Innovation in Neurology
American Academy of Neurology 2024
Startup of the Year
Health 2.0 2024
Powered By Cutting-Edge Tech
Enterprise-grade infrastructure and AI
AI & Machine Learning
- TensorFlow & PyTorch
- Deep Neural Networks
- Ensemble Models
- Real-time Inference
Security & Compliance
- HIPAA Compliant
- SOC 2 Type II
- End-to-End Encryption
- Zero-Trust Architecture
Cloud Infrastructure
- 99.9% Uptime SLA
- Auto-Scaling
- Global CDN
- Real-time Monitoring
Trusted Partners
Collaborating with world-leading institutions
Academic Partners
Clinical Partners
Join Us In Our Mission
Whether you're a patient, healthcare provider, researcher, or investor - there's a place for you in our journey to revolutionize early detection.